Charpentier MS et al. (2013), CASZ1 promotes vascular assembly and morphogene...

XB-ART-47030

Dev Cell 2013 Apr 29;252:132-43. doi: 10.1016/j.devcel.2013.03.003.

Show Gene links Show Anatomy links

CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway.

Charpentier MS , Christine KS , Amin NM , Dorr KM , Kushner EJ , Bautch VL , Taylor JM , Conlon FL .

???displayArticle.abstract???
The formation of the vascular system is essential for embryonic development and homeostasis. However, transcriptional control of this process is not fully understood. Here we report an evolutionarily conserved role for the transcription factor CASZ1 (CASTOR) in blood vessel assembly and morphogenesis. In the absence of CASZ1, Xenopus embryos fail to develop a branched and lumenized vascular system, and CASZ1-depleted human endothelial cells display dramatic alterations in adhesion, morphology, and sprouting. Mechanistically, we show that CASZ1 directly regulates Epidermal Growth Factor-Like Domain 7 (Egfl7). We further demonstrate that defects of CASZ1- or EGFL7-depleted cells are in part due to diminished RhoA expression and impaired focal adhesion localization. Moreover, these abnormal endothelial cell behaviors in CASZ1-depleted cells can be rescued by restoration of Egfl7. Collectively, these studies show that CASZ1 is required to directly regulate an EGFL7/RhoA-mediated pathway to promote vertebrate vascular development.

???displayArticle.pubmedLink??? 23639441
???displayArticle.pmcLink??? PMC3641863
???displayArticle.link??? Dev Cell
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: aplnr casz1 egfl7 gnl3 kdr npat pecam1 rhoa rps29
???displayArticle.morpholinos??? casz1 MO1 casz1 MO2 egfl7 MO1 egfl7 MO2

???attribute.lit??? ???displayArticles.show???

	Figure 1. CASZ1 Expression in Vascular ECs Is Evolutionarily Conserved (A) In situ analysis of Casz1 Xenopus embryos (stage 41; lateral view with anterior to the left). Casz1 is expressed in vascular structures, including the vitelline vein network (vvn; enlarged panel on the right). (B) CASZ1 (green) colocalizes with PECAM (red) in neural blood vessels of E14.5 mouse embryos. (C) RT-PCR analysis of human Casz1 in HUVEC cDNA. Gapdh was used as loading control. (D) IP of CASZ1 from HUVECs. Control lane (left) represents IP with no antibody (Ab). Arrowhead represents 125 kD human CASZ1. See also Figure S1.
	Figure 2. CASZ1 Is Required for Vascular Development and Lumen Formation (Aï¿½H) In situ analysis with EC marker Msr of control and CASZ1-depleted embryos (stages 32ï¿½36; lateral view with anterior to the left). Vessel patterning and branching within the vvn are severely compromised at stage 32 in CASZ1-depleted embryos (A and C: high magnification of the vvn in B and D) and stage 36 (E and G: high magnification of the vvn in F and H). Note the poor sprouting of intersomitic vessels (isv) in CASZ1-depleted embryos at both stages (enlarged box in A, C, E, and G). n = 10 embryos/condition/stage, three independent experiments. pcv, posterior cardinal vein. (I) Quantification of vascular defects in control and CASZ1-depleted embryos (stage 36) representing the combined total length of vessels, number of branch points within the vvn, and number of isv/embryo, respectively. Data represent mean ï¿½ SEM (n = 7 control and 10 Casz1 MO embryos). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. (Jï¿½Q) Histological analysis illustrates the time course of lumen formation in Xenopus from stage 29 to stage 39 (Jï¿½M). Note that posterior cardinal vein (pcv) lumens begin to open between stages 32 and 36 in control embryos (K and L) but fail to form in CASZ1-depleted embryos (Nï¿½Q). Dorsal is top, ventral is bottom. Arrowheads correspond to positions of pcv that are enlarged in lower panels (n = 2ï¿½5 embryos/condition/stage). See also Figure S1.
	Figure 4. CASZ1 Directly Activates Egfl7 Transcription (A) Illustration of cardiovascular-enriched region dissected from X. tropicalis for ChIP. (B) Genomic structure of the Xenopus Egfl7 locus, denoting a CASZ1 ChIP fragment. White boxes: exons; shaded boxes: miR-126 in intron 7 and intronic region potentially containing CASZ1 element (ï¿½4 kb). (Cï¿½J) In situ analysis of Egfl7 of stage 29ï¿½39 control and CASZ1-depleted embryos (lateral view with anterior to the left). Note the downregulation of Egfl7 in the vvn and isv of CASZ1-depleted embryos. (K) Relative mRNA expression of Egfl7, miR-126, and Flk1 after infection of HUVECs with shCasz1. mRNA levels relative to Rps29 ï¿½ SEM. âˆ—âˆ—âˆ—p < 0.001; NS: not significant. (L) Schematic demarcating Egfl7 genomic DNA regions (in bp) tested for transcriptional activation. E1 (âˆ’55 to 1,614) within intron 3 but not E2 (1,773ï¿½3,840) resulted in increased luciferase (luc) activity. (M) Egfl7 genomic region E1 in the presence or absence of Casz1. Bars represent fold increase in activity relative to control ï¿½ SEM. Experiments were repeated twice on independent batches of embryos; âˆ—âˆ—p < 0.01. (N) Identification of a 90 bp region endogenously bound by CASZ1 located within a nonoverlapping region of the E1.2 (113ï¿½227) PCR amplicon. See also Figure S3 and Table S1.
	Figure 5. EGFL7 Depletion in Embryos and HUVECs Phenocopies CASZ1 Depletion (Aï¿½H) In situ analysis with EC marker Msr of control and EGFL7-depleted embryos (stages 32ï¿½36, lateral view with anterior to left). Note the lack of branching in the vvn at stage 32 (A and C: high magnification of the vvn in B and D) and stage 36 (E and G: high magnification of the vvn in F and H); isv sprouting is also impaired (A, C, E, and G). n = 10 embryos/condition/stage, three independent experiments. (I) Quantification of vascular defects in control and EGFL7-depleted embryos (stage 36) representing total vessel length, number of branch points within the vvn, and number of isv/embryo. Data represent mean ï¿½ SEM (n = 7 control and 10 Egfl7 MO embryos). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0005. (Jï¿½M) Histological analysis reveals lumenless pcv in stage 36 (K) and stage 39 (M) EGFL7-depleted embryos compared to control (J and L). Top: dorsal; bottom: ventral; arrowheads correspond to pcv positions enlarged in lower panels (n = 3 embryos/condition/stage). (N) mRNA expression of Egfl7, miR-126, Casz1, and Flk1 after infection of HUVECs with shEgfl7. Egfl7 is decreased 11-fold. mRNA levels relative to Rps29 ï¿½ SEM. ∗∗∗p < 0.001; NS, not significant. (O) Quantification of cells that round up and detach during imaging. Data represent the mean ï¿½ SEM of two experiments conducted on independent batches of shRNA-infected cells. n = 100 cells; ∗∗p < 0.01. (P) A sprouting angiogenesis assay was performed with control and EGFL7-depleted HUVECs. On day 6, cultures were fixed and stained for phalloidin (green) and DRAQ5 (blue). Graphs represent the mean ï¿½ SEM of total sprout length and number of branch points/bead (n = 11 beads/condition). Experiments were repeated twice on independent batches of shRNA-infected cells. ∗∗p < 0.01, ∗∗∗p < 0.001. See also Figures S4 and S5 and Movies S2 and S5.

References [+] :

Baltzinger, Xl erg: expression pattern and overexpression during development plead for a role in endothelial cell differentiation. 1999, Pubmed, Xenbase